Signal Transduction in the Immune System-FASEB Summer Conference

描述（由申请人提供）：本申请寻求FASEB夏季会议的“免疫系统中的信号转导”，将于2009年6月21日至26日在斯诺马斯，科罗拉多部分资金。本次会议的主要目标是全面关注有关健康和疾病中免疫细胞反应的信号机制的最新进展。这将是第五届FASEB会议，过去的会议分别在2000年、03年、05年和07年举行。这次会议已经在研究机构，学术界和工业界引起了广泛的兴趣，因为杰出的发言者名单，所提出的工作的前沿性和许多演讲与免疫疾病的相关性。此外，由于大多数主流免疫学会议并不深入关注信号转导机制，因此针对这一研究领域的单独FASEB会议已将会议确立为许多研究人员的高调论坛。这个FASEB会议的每一个版本都有越来越多的出席者，2007年是FASEB夏季会议中出席人数最多的一次。会议吸引了世界各地免疫信号转导领域的领导者以及新的研究人员和学生。计划于2009年举行的会议将涵盖一系列主题，重点是先天免疫信号机制。2009年的会议还将有一个指定的会议，为研究人员从领先的制药集团提供最新的治疗发展免疫疾病。虽然会议有一个骨干的定期与会者和发言者，以确保新的想法和领域得到解决，2009年的会议将有17个新的发言者（共29个邀请会谈）。此外，每次会议都有空间从摘要中选择一个或几个简短的演讲，优先考虑新的研究者或来自PI未发表的小组的博士后。这将确保会议议题的多样性。会议的总体目标是：1.提供一个关键的和密集的概述免疫信号的最新进展，强调先天免疫信号; 2。将资深科学家和年轻研究人员聚集在一起，在轻松愉快的气氛中进行演讲和非正式讨论，以培养学生和年轻研究人员的热情和研究技能; 3.通过广泛传播信息和最新突破，快速推进免疫系统分子机制的研究。因此，希望这次会议将建立在过去会议的成功影响免疫信号研究的方向。

DESCRIPTION (provided by applicant): This application seeks partial funding for a FASEB Summer Conference on "Signal Transduction in the Immune System", to be held June 21-26, 2009 in Snowmass, Colorado. The major goal of this conference is to provide a comprehensive focus on recent advances regarding the signaling mechanisms involved in the response of immune cells in both health and disease. This will be the 5th version of this FASEB conference, with past meetings held in 2000, '03, '05 and '07. This conference has garnered widespread interest in research institutes, academia, and industry because of the outstanding speaker rosters, the cutting edge nature of the work presented and the relevance of many presentations to immunologic diseases. Additionally, since most mainstream immunology meetings do not provide an in-depth focus on signal transduction mechanisms, having this separate FASEB conference for this area of investigation has established the meeting as high profile forum for many investigators. Each version of this FASEB conference has seen increasing attendance, with 2007 being one of the most highly attended FASEB Summer conferences in general. The meeting attracts the leaders in immune signal transduction world-wide as well as new investigators and students. The meeting planned for 2009 will cover a spectrum of topics, with an emphasis on innate immune signaling mechanisms. The 2009 conference will also have a designated session for investigators from leading pharmaceutical groups to provide updates on therapeutic developments in immunologic disease. Though the conference has a backbone of regular attendees and speakers, to ensure that new ideas and areas are addressed, the 2009 conference will feature 17 new speakers (out of a total of 29 invited talks). In addition, each session has space for one or several short talks to be selected from abstracts, with priority given to new investigators or post-docs from groups in which PIs are not presenting. This will ensure a diversity of topics at the meeting. The overall objectives of the meeting are: 1. To provide a critical and intensive overview of the recent advances in immune signaling, emphasizing innate immune signaling; 2. To bring together senior scientists and young investigators in a convivial atmosphere of presentation and informal discussion to engender the enthusiasm and investigative skills of students and young investigators; 3. To rapidly advance the research on the molecular mechanisms in the immune system by broadly disseminating information and recent breakthroughs. Thus, it is hoped that this conference will build upon the success of past conferences in influencing the direction of immune signaling research.